June 2026 Terumo Interventional Systems announced the first U.S. clinical procedure using its OPUSWAVE® Dual Sensor Imaging System, which combines Optical Frequency Domain Imaging (OFDI) and Intravascular Ultrasound (IVUS) in a single catheter to improve visualization and diagnosis during coronary interventions.
April 2026 Boston Scientific received U.S. FDA 510(k) clearance for its expanded OptiCross™ Coronary Imaging Catheter portfolio, including OptiCross HD and OptiCross 6 HD models, strengthening its intravascular ultrasound (IVUS) imaging solutions for coronary artery disease diagnosis.
February 2026 Medtronic announced its agreement to acquire CathWorks in a deal valued at up to USD 585 million. The acquisition expands Medtronic's coronary diagnostics portfolio by adding the FFRangio® System, a non-invasive technology for assessing coronary artery disease.
October 2025 Philips Image Guided Therapy (Volcano Corporation) received U.S. FDA 510(k) clearance for the Visions® PV Digital IVUS Catheters, expanding its intravascular ultrasound imaging portfolio for coronary artery disease diagnosis and image-guided interventions.